Islam A F, Garg S K, Bhargava V K
Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Indian J Exp Biol. 1999 Jan;37(1):86-8.
Present study was undertaken to determine if an interaction exists during co-administration of ciprofloxacin with phenytoin. Eight healthy male rabbits received oral phenytoin, 40 mg/kg, od, for 7 days. On day 7, phenytoin blood sampling was done at times 0, 0.1, 1, 2, 3, 4, 5, 6, 8 and 24 hr. From day 8 to 14, phenytoin was co-administered with oral ciprofloxacin, 70 mg/kg, od. On day 14, blood samples were collected as previously described. Pharmacokinetic analysis revealed significant decrease in steady state maximum concentration (Cmax), through concentration (Cmin), elimination half life (t 1/2 e) and the area under plasma time concentration curve (AUC0-24) of phenytoin when co-administered with ciprofloxacin. It warrants close monitoring of levels when these two agents are given simultaneously.
本研究旨在确定环丙沙星与苯妥英钠联合使用时是否存在相互作用。八只健康雄性兔子口服苯妥英钠,剂量为40mg/kg,每日一次,共7天。在第7天,于0、0.1、1、2、3、4、5、6、8和24小时采集苯妥英钠血样。从第8天至第14天,苯妥英钠与口服环丙沙星联合使用,剂量为70mg/kg,每日一次。在第14天,按照之前描述的方法采集血样。药代动力学分析显示,当苯妥英钠与环丙沙星联合使用时,其稳态最大浓度(Cmax)、谷浓度(Cmin)、消除半衰期(t1/2e)以及血浆时间浓度曲线下面积(AUC0-24)均显著降低。当同时给予这两种药物时,有必要密切监测其血药浓度。